AU5369996A - Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases - Google Patents
Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseasesInfo
- Publication number
- AU5369996A AU5369996A AU53699/96A AU5369996A AU5369996A AU 5369996 A AU5369996 A AU 5369996A AU 53699/96 A AU53699/96 A AU 53699/96A AU 5369996 A AU5369996 A AU 5369996A AU 5369996 A AU5369996 A AU 5369996A
- Authority
- AU
- Australia
- Prior art keywords
- diseases
- treatment
- methods
- monoclonal antibody
- antibody against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40985195A | 1995-03-23 | 1995-03-23 | |
US409851 | 1995-03-23 | ||
PCT/US1996/003965 WO1996029348A1 (en) | 1995-03-23 | 1996-03-22 | Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5369996A true AU5369996A (en) | 1996-10-08 |
Family
ID=23622245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53699/96A Abandoned AU5369996A (en) | 1995-03-23 | 1996-03-22 | Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5369996A (en) |
WO (1) | WO1996029348A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6362325B1 (en) | 1988-11-07 | 2002-03-26 | Advanced Research And Technology Institute, Inc. | Murine 4-1BB gene |
US6303121B1 (en) * | 1992-07-30 | 2001-10-16 | Advanced Research And Technology | Method of using human receptor protein 4-1BB |
IL129138A0 (en) * | 1996-10-11 | 2000-02-17 | Bristol Myers Squibb Co | Methods and compositions for immunomodulation |
KR20000034847A (en) * | 1998-11-17 | 2000-06-26 | 성재갑 | Humanized Antibody Specific for Human 4-1BB Molecule and Pharmaceutical Composition Comprising Same |
AU784634B2 (en) | 1999-11-30 | 2006-05-18 | Mayo Foundation For Medical Education And Research | B7-H1, a novel immunoregulatory molecule |
KR100468321B1 (en) * | 2001-02-08 | 2005-01-27 | 학교법인 울산공업학원 | Polypeptides for treatment of cancers and AIDS |
AU2002364935A1 (en) | 2001-10-09 | 2003-06-23 | Mayo Foundation For Medical Education And Research | Enhancement of immune responses by 4-1bb-binding agents |
KR100452954B1 (en) * | 2002-02-26 | 2004-10-14 | 주식회사 엘지생명과학 | Manufacturing Method of Enhancing binding affinity of Humanized antibody specific for human 4-1BB molecule through modifying amino acid substitutions in variable region |
WO2004055513A2 (en) * | 2002-12-16 | 2004-07-01 | Herbert Schwarz | Use of cd137 antagonists for the treatment of tumors |
US7288638B2 (en) | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
AR046094A1 (en) * | 2003-10-10 | 2005-11-23 | Bristol Myers Squibb Co | COMPLETELY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB |
HUE039237T2 (en) | 2004-10-06 | 2018-12-28 | Mayo Found Medical Education & Res | B7-h1 and pd-1 in treatment of renal cell carcinoma |
WO2010042433A1 (en) | 2008-10-06 | 2010-04-15 | Bristol-Myers Squibb Company | Combination of cd137 antibody and ctla-4 antibody for the treatment of proliferative diseases |
SG10201506906VA (en) | 2010-09-09 | 2015-10-29 | Pfizer | 4-1bb binding molecules |
US9302005B2 (en) | 2013-03-14 | 2016-04-05 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
ES2714708T3 (en) | 2013-10-01 | 2019-05-29 | Mayo Found Medical Education & Res | Procedures for the treatment of cancer in patients with elevated levels of Bim |
US10302653B2 (en) | 2014-05-22 | 2019-05-28 | Mayo Foundation For Medical Education And Research | Distinguishing antagonistic and agonistic anti B7-H1 antibodies |
US10517875B2 (en) | 2014-07-23 | 2019-12-31 | Mayo Foundation for Medical Engineering and Research | Targeting DNA-PKcs and B7-H1 to treat cancer |
WO2017075045A2 (en) | 2015-10-30 | 2017-05-04 | Mayo Foundation For Medical Education And Research | Antibodies to b7-h1 |
WO2018134787A2 (en) | 2017-01-20 | 2018-07-26 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of cd137+ cells |
WO2019141268A1 (en) * | 2018-01-22 | 2019-07-25 | 江苏恒瑞医药股份有限公司 | Anti-4-1bb antibody, antigen-binding fragment thereof and medical use thereof |
CA3169910A1 (en) | 2020-02-28 | 2021-09-02 | Shanghai Henlius Biotech, Inc. | Anti-cd137 constructs, multispecific antibody and uses thereof |
CA3169939A1 (en) | 2020-02-28 | 2021-09-02 | Jie Xue | Anti-cd137 construct and use thereof |
-
1996
- 1996-03-22 AU AU53699/96A patent/AU5369996A/en not_active Abandoned
- 1996-03-22 WO PCT/US1996/003965 patent/WO1996029348A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1996029348A1 (en) | 1996-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5369996A (en) | Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases | |
ATE348113T1 (en) | RECOMBINANT ANTI-CD4 ANTIBODY FOR HUMAN TREATMENT | |
HUP9802401A3 (en) | Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy | |
ZA964434B (en) | Neutralizing high affinity human monoclonal antibodies specific to rsv f-protein and methods for their manufacture and therapeutic use thereof | |
HUP9902327A3 (en) | Humanized antibodies to human gp39, compositions containing and therapeutic use thereof | |
EP0921815A4 (en) | Therapeutic uses of humanized antibodies against alpha-4 integrin | |
AU1704099A (en) | Monoclonal human natural antibodies | |
EP1043335A4 (en) | Monoclonal antibody against connective tissue growth factor and medicinal uses thereof | |
EP0880597A4 (en) | THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 | |
AU6887698A (en) | Study and treatment of diseases related to specific cellular functions of receptor protein tyrosine kinases | |
EP0870826A4 (en) | Novel protein and monoclonal antibody specific thereto | |
AU7248594A (en) | Peptides and antibodies to human c5a receptor and method of treatment | |
AU2990695A (en) | Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer | |
SG52342A1 (en) | T cell antigen receptor v region protein and methos of preparation thereof | |
HK1043937A1 (en) | Human therapeutic uses of bpi protein products | |
EP0831793A4 (en) | Protein particles for therapeutic and diagnostic use | |
AU5021796A (en) | Recombinant human anti-lewis b antibodies | |
AU4274293A (en) | Human monoclonal antibodies against cytomegalovirus and method for preparation thereof | |
AU3923293A (en) | Human monoclonal antibodies and methods for human monoclonal antibody production | |
AU6284896A (en) | Obesity protein intermediates and their preparation and use | |
HU9403720D0 (en) | Multimeric forms of human rhinovirus receptor protein | |
AUPN115095A0 (en) | Analysis of and compositions and methods for the treatment of disease | |
AU2170692A (en) | Me20: monoclonal antibodies and antigen for human melanoma | |
AU5568396A (en) | Methods of screening for therapeutic agents using novel apop tosis-modulating proteins | |
AU1270099A (en) | Human progesterone receptor complex p23-like protein |